◆ NeutralWGS
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.·
GeneDx Holdings Corp. faces a securities fraud class action lawsuit for failing to disclose material information about its Fabric Genomics acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and took a $31.2 million impairment loss, resulting in a 49.2% stock price decline. Investors who purchased shares between April 16, 2025 and May 4, 2026 can file lead plaintiff applications by August 3, 2026.
Read Full Article at GlobeNewswire Inc. →